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Abstract
Introduction: Multiple endocrine neoplasia 2B, a rare autosomal dominant syndrome, is characterized by early
onset of medullary thyroid carcinoma, pheochromocytoma, marfanoid habitus and mucosal neuromas of the
tongue, lips, inner cheeks and inner eyelids. Gangliomatosis of the gastrointestinal tract and its complications may
also occur in patients with this disease.
Case presentation: We present the case of a 16-year-old Persian man diagnosed as having a non-invasive form of
multiple endocrine neoplasia 2B (medullary thyroid cancer, mucosal neuroma of the tongue, lips and inner eyelids).
Our patient, who had a positive family history of medullary thyroid cancer, was of normal height with no signs of
marfanoid habitus.
Conclusions: Ophthalmological and oral manifestations of multiple endocrine neoplasia 2B, as in the case of our
patient, are rare presentations of the disease; unfortunately in the case of our patient his condition had not been
noted and acted upon until he presented to our department. The diagnosis in our patient’s case was made only
after his mother presented with the same condition. As a result, we emphasize that physicians should pay more
attention to the oral and ocular signs of multiple endocrine neoplasia 2B in order to diagnose this fatal syndrome
at an earlier phase.
Introduction
Multiple endocrine neoplasia 2B (MEN2B) is a rare
autosomal dominant syndrome [1-4]. It is diagnosed by
early onset medullary thyroid carcinoma (MTC), pheo-
chromocytoma, marfanoid habitus and mucosal neuro-
mas of the tongue, lips, inner cheeks and inner eyelids.
Gangliomatosis of the gastrointestinal tract and its
complications may also occur in these patients [5-7].
MTC arises from C cells (which secret calcitonin) of
the thyroid gland [8,9]. The hereditary forms of MTC
occur as a part of MEN2B, associated with germline
mutation of the RET proto-oncogene [1,10]. The repla-
cement of methionine with threonine (M918T) occurs
in more than 95% of these patients [2,3,5].
After ruling out pheochromocytoma, prophylactic
t h y r o i d e c t o m ys h o u l db ep e r f o r m e db e f o r et h ea g eo f
six months to treat MTC in patients with MEN2B
[2,4,6-8,11]. Here, we report a case of MEN2B in a
patient, recognized only after his mother was found to
have the same disease.
Case presentation
A 16-year-old Persian man visited a referral hospital
after his mother was diagnosed as having aggressive
MTC. The 38-year-old woman, who had had a mass in
the thyroid gland and cervical lymphadenopathy for six
years, underwent thyroidectomy a year earlier after
being diagnosed as having the disease. Her family mem-
bers were then asked to visit a physician for further eva-
luation as the disease usually runs in the family.
Our patient had no history of the main symptoms of
the disease, namely lymphadenopathy (LAP), weight loss,
fever, café au lait spots, ocular problems, gastrointestinal
problems (failure to thrive (FTT), abdominal pain, dys-
phagia, projectile vomiting, diarrhea, constipation, flatu-
lence), thyroid nodule, hoarseness, dyspnea and cough.
On physical examination, his face was symmetric and
there was no sign of high arched palate, mandibular
* Correspondence: mrmohajeri@sina.tums.ac.ir
1Endocrinology & Metabolism Research Center, Tehran University of Medical
Sciences, Tehran, Iran
Full list of author information is available at the end of the article
Majidi et al. Journal of Medical Case Reports 2011, 5:587
http://www.jmedicalcasereports.com/content/5/1/587 JOURNAL OF MEDICAL
CASE REPORTS
© 2011 Majidi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.prognathism, and flat nasal bridge. He, however, had
bumpy lips and several neuromas on his upper and
lower eyelids, lips and tongue, all characteristic of
MEN2B. His thyroid gland and abdomen were normal,
and there were no other remarkable finding in the phy-
sical examination. He had a normal height with no signs
of marfanoid habitus. He had increased calcitonin and
carcinoembryonic antigen (CEA) levels but tests for
RET proto-oncogene on exon 10, 11 and 16 were
negative.
The results of an ophthalmology examination showed
several mucosal neuromas on inner eyelids and conjuncti-
vae, prominent perilimbal conjunctival blood vessels and
enlarged corneal nerves. His intra-ocular pressure (IOP)
was normal. His upper gastrointestinal and small bowel
series were also normal.
Pheochromocytoma was ruled out based on the labora-
tory test results. Our patient thereafter underwent a thyr-
oidectomy. The results of pathological tests revealed a
small (0.5cm) medullary thyroid carcinoma in right lobe,
with surgical margins free of tumor.
Post-operative evaluation, including cervical ultrasound
as well as cervical, thoracic and abdominal computed
tomography, were normal. Our patient’s calcitonin and
CEA levels were then assessed periodically.
It should be noted that all the family members had
signed an informed consent, providing the authors with
an authorization to publish their information.
Discussion
The majority of patients with MEN2B experience two
main symptoms, MTC and pheochromocytoma. Indivi-
duals with MEN 2B show a variety of additional condi-
tions, including a characteristic facial appearance with
swollen lips, neuromas of the mucous membranes of the
eye, mouth, tongue, and nasal cavity, enlarged colon, and
skeletal abnormalities [11-13].
MTC in MEN2B, which usually develops early in life, is
multi-centric and bilateral. Considering the high risk of
early metastasis (to the liver and lungs) and the aggressive
and life-threatening nature of MTC in MEN2B, it is vital
to recognize the condition as soon as possible [6,7,9]. In
view of the fact that our case was asymptomatic, he was
diagnosed as having the disease only because his mother
was a known case of aggressive MTC.
As prophylactic thyroidectomy before the age of six
months is recommended in MEN2B cases presenting
with MTC, our patient underwent the surgery as soon as
he was diagnosed as having the disease [8].
T h em u t a t i o no fe x o n1 6o ft h eR E Tp r o t o - o n c o g e n e
located on chromosome 10 is reported in 95% of MEN2
cases [9]. This comes while a few MEN2 cases (as our
case) have been described to be negative for the RET
mutations, suggesting that the mutation of other loci
may also predispose an individual to developing the dis-
ease [14,15].
Mucosal neuromas of the tongue, lips, inner cheeks and
inner eyelids are hallmark diagnostic findings in MEN2B
[8,16]. Mucosal neuromas of the tongue, as reported in
our patient’s case, are almost pathogonomic of MEN2B in
the presence of MTC [15]. Many primary care physicians,
however, fail to detect these neuromas because of the
scarce nature of MEN2B and their unfamiliarity with its
symptoms [8].
T h e r ew e r en os i g n so fm a r f a n o i dp h e n o t y p e ,w h i c h
usually become apparent during puberty or early adoles-
cence, in our patient’s case [6].
The ophthalmological disorders accompanying with
MEN2B are photophobia, ptosis, everted eyelids, neuro-
mas of the eyelid and conjunctivae, dryness of the eye,
increased intra-ocular pressure (IOP), prominent corneal
nerves and enlarged perilimbal conjuctival vessels [6,12].
These manifestations are seen in 86% of patients at the
time of diagnose [6,10,12]. Prominent corneal nerves,
which were also noted in our patient, are characteristic of
MEN2B [10-13]; it, however, may be reported in other
syndromes as well and that could be the reason that our
patient remained undiagnosed for many years despite hav-
ing these typical features [10,11,13]. Early detection of
such symptoms can prevent from the development of
other life threatening complications of the syndrome
[11,12,17].
Gastrointestinal symptoms such as FTT, abdominal
pain, dysphagia, projectile vomiting, diarrhea, constipa-
tion, flatulence, intussusceptions, megacolon, and pseudo
obstruction are considered as possible manifestations of
MEN2B [9]. Based on the results of physical examination
and imaging, there were no signs of these symptoms,
mainly referred to as gangliomatosis of the gastrointest-
inal tract, in our patient. There are several reports show-
ing numerous MEN2B cases remaining undiagnosed
despite having diagnostic oral characteristics [6].
Conclusions
T h ep r e s e n ta r t i c l er e p o r t sar a r ec a s eo fM E N 2 Bw i t h
ophthalmological and oral manifestations that was only
diagnosed after our patient’sm o t h e rw a sd i a g n o s e da s
having the same disease. We therefore urge physicians to
pay more attention to the oral and ocular signs of
MEN2B, as early diagnosis can prevent further complica-
tions of this fatal disease.
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